Japan Pharma New Year Resolutions – Challenges Must Be Identified Concretely To Make Growth Reality
This article was originally published in PharmAsia News
The identification of concrete problems stood out as the main objective for many major Japanese pharmaceutical companies as New Year announcements were made Jan. 7.
You may also be interested in...
A pilot that used RFID tags with 2D barcodes was touted as more effective than using 2D barcodes alone in tracking drugs through the supply chain.
The current pandemic has accelerated the US FDA’s perspective on conducting remote clinical trials. The agency has published an emergency guidance to allow sponsors to continue their work, which a former FDA official says is an indication of where the agency is headed post-COVID-19.
Facing ongoing shortages, the US FDA is allowing most surgical masks to be used as personal protective equipment under a new emergency use authorization.